These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23995396)

  • 41. Optimal sampling time for single-sample (Christensen-Groth) 51Cr-EDTA estimation of glomerular filtration rate.
    Watson WS
    Nucl Med Commun; 1996 Jun; 17(6):542, 544. PubMed ID: 8822755
    [No Abstract]   [Full Text] [Related]  

  • 42. Indexing glomerular filtration rate to suit children.
    Bird NJ; Henderson BL; Lui D; Ballinger JR; Peters AM
    J Nucl Med; 2003 Jul; 44(7):1037-43. PubMed ID: 12843217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How good is the slope of the second exponential for estimating 51Cr-EDTA renal clearance?
    Piepsz A; Ham HR
    Nucl Med Commun; 1997 Feb; 18(2):139-41. PubMed ID: 9076769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimation of glomerular filtration rate in children.
    Léger F; Bouissou F; Coulais Y; Tafani M; Chatelut E
    Pediatr Nephrol; 2002 Nov; 17(11):903-7. PubMed ID: 12432431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Determination of glomerular filtration rate with 51 Cr-EDTA: evaluation of the method utilizing a single intravenous injection and the blood clearance curves].
    Takasugi M; Kimura K; Kozuki Y; Konomigi S; Hirota T
    Nihon Rinsho; 1973 Oct; 31(10):2987-93. PubMed ID: 4204608
    [No Abstract]   [Full Text] [Related]  

  • 46. Correction factors after having neglected the first exponential in the estimation of chromium-51 EDTA clearance: a reappraisal.
    De Sadeleer C; Piepsz A; Ham HR
    Ann Nucl Med; 2006 Feb; 20(2):95-8. PubMed ID: 16615417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimation of chromium-51 ethylene diamine tetra-acetic acid plasma clearance: a comparative assessment of simplified techniques.
    Picciotto G; Cacace G; Cesana P; Mosso R; Ropolo R; De Filippi PG
    Eur J Nucl Med; 1992; 19(1):30-5. PubMed ID: 1547805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reproducibility of simplified techniques for the measurement of 51Cr-EDTA clearance.
    Piepsz A; Tondeur M; Ham HR
    Nucl Med Commun; 1996 Dec; 17(12):1065-7. PubMed ID: 9004304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How good is the slope on the second exponential for estimating 51Cr-EDTA renal clearance? A Monte Carlo simulation.
    De Sadeleer C; Piepsz A; Ham HR
    Nucl Med Commun; 2000 May; 21(5):455-8. PubMed ID: 10874703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of 51Cr-EDTA clearance between 15 and 40 ml/min/1.73 m2 by a single plasma sample.
    Groth S; Aasted M
    Scand J Clin Lab Invest; 1989 Dec; 49(8):711-7. PubMed ID: 2515588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of time interval and number of blood samples on the error in renal clearance determination using a mono-exponential model: a Monte Carlo simulation.
    De Sadeleer C; Van Laere K; Georges B; Piepsz A; Ham HR
    Nucl Med Commun; 2000 Aug; 21(8):741-5. PubMed ID: 11039457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacokinetics of cefotaxime in cirrhotic patients with or without ascites].
    Vincent P; Colombel JF; Husson MO; Izard D; Paris JC; Leclerc H
    Presse Med; 1988 Dec; 17(44):2331-4. PubMed ID: 2974968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measurement of glomerular filtration rate with chromium-51 ethylene diamino tetraacetic acid in the presence of gallium-67 citrate: a novel method for the solution of the problem.
    Arsos G; Moralidis E; Tsechelidis I; Sakagiannis G; Sidiropoulou V; Psarouli E
    Nucl Med Commun; 2011 Mar; 32(3):221-6. PubMed ID: 21178647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adaptation of a single injection clearance method to physiological and pathophysiological facts. A review of data obtained in infancy and childhood.
    Wassmer M; Schafroth M; Bretscher D; Schneider A; Oetliker O
    Acta Paediatr Scand; 1977 Jul; 66(4):425-30. PubMed ID: 409096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ascites dynamics in cirrhosis. Proposal and validation of a methylene blue dilution test.
    Milani A; Ciammella AM; Degen C; Siciliano M; Rossi L
    J Hepatol; 1992 Nov; 16(3):369-75. PubMed ID: 1336786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Robustness of slope-intercept versus slope-only for measurement of glomerular filtration rate.
    Peters AM
    Nucl Med Commun; 2001 Jan; 22(1):115-7. PubMed ID: 11233546
    [No Abstract]   [Full Text] [Related]  

  • 57. Reevaluation of formulas for predicting creatinine clearance in adults and children, using compensated creatinine methods.
    Wuyts B; Bernard D; Van den Noortgate N; Van de Walle J; Van Vlem B; De Smet R; De Geeter F; Vanholder R; Delanghe JR
    Clin Chem; 2003 Jun; 49(6 Pt 1):1011-4. PubMed ID: 12766016
    [No Abstract]   [Full Text] [Related]  

  • 58. Renal retention of sodium in cirrhosis and fulminant hepatic failure.
    Wilkinson SP; Moodie H; Alam A; Williams R
    Postgrad Med J; 1975 Aug; 51(598):527-31. PubMed ID: 1234336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New calculation method of mean total body clearance of drugs and its application to dosage regimens.
    Chiou WL
    J Pharm Sci; 1980 Jan; 69(1):90-1. PubMed ID: 7354453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of relationship between CA-125 levels and ascites in patients with liver cirrhosis.
    Kayadibi H; Sertoglu E; Uyanik M
    J Coll Physicians Surg Pak; 2014 Nov; 24(11):873. PubMed ID: 25404453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.